Interestingly, we also found that the AFP of the cirrhotic group was significantly higher than that of the noncirrhosis group among CHB patients, but AFP showed no significant difference between the cirrhosis and without cirrhosis groups in HBV‐HCC patients. This evidence concerns the gene AFP and hepatocellular carcinoma.